[Ip-health] Event: Promoting quality medicines and saving lives
bagozzid at who.int
Wed Sep 30 07:22:10 PDT 2015
Promoting quality medicines and saving lives – Commemorating the 50th anniversary of WHO programme to improve medicines quality worldwide
Pharmaceutical production and regulation have become highly sophisticated in the last few decades, bringing some new and highly effective medicines to market. Medicines quality, on the other hand, remains a challenge. Defective medicines alerts continue to be raised from all corners of the world and shortages of life-saving medicines-linked to manufacturing quality problems in many cases-have become a global concern.
Ensuring the quality and safety of medicines is a highly specialized task, which has become too complex for any government to perform on its own. Regulatory authorities increasingly call for collaboration, joint decision-making and a common point of reference. WHO, by working with its 194 Member States and with its knowledge of developing country challenges, has provided that point of reference for almost 60 years by developing and promoting international quality standards for medicines through its Expert Committee on Specifications for Pharmaceutical Products and its International Pharmacopoeia.
You are cordially invited to hear experts explain WHO’s work to promote quality medicines worldwide and country representatives describe their struggles and efforts to protect their populations from harmful medicines.
When: 15 October 2015, at 2.00 p.m.
Where: Club suisse de la presse, Route de Ferney 106, 1202 Geneva
- Dr Lembit Rago, Director, Regulation of Medicines and other Health Technologies, WHO. Global challenges and solutions to ensuring quality medicines and protecting patients.
- Ms Gugu N. Mahlangu, Director-General, Medicines Control Authority of Zimbabwe.
Access to medicines and how WHO guidelines can help national authorities.
- Professor Jin Shaohong, Chief Expert for Pharmaceutical Products, National Institutes for Food and Drug Control, China. Update on China’s efforts to protect its population against bad quality medicines.
- Mr David Churchward, Inspector, Medicines and Healthcare products Regulatory Agency, UK. The new global model-challenges and opportunities for medicines supply from a national regulator’s perspective.
The speakers will make short presentations and then open the floor for questions and discussions. Refreshments will be served after the event.
More information about the Ip-health